Spring Health has announced its acquisition of Alma, a platform dedicated to supporting independent mental health clinicians, aiming to enhance accessible and effective mental health care delivery.

Information on the Target

Spring Health, a prominent global mental health platform, specializes in providing services to employers and health plans. Recently, the company announced its intention to acquire Alma, a membership-based platform that supports independent mental health clinicians in accepting insurance and establishing successful private practices. Though the financial terms of this transaction remain undisclosed, the collaboration aims to enhance accessibility to mental health care.

Founded by Harry Ritter in 2018, Alma has successfully raised a total of $220.5 million in equity funding from a range of investors, including Thoma Bravo, Insight Partners, Cigna Ventures, and others. The platform developed by Alma enables clinicians to provide care to over 120 million lives via agreements with both national and regional payers. Following the acquisition, Alma’s platform will be integrated into Spring Health’s product offerings, thereby improving mental health care delivery for insurers, providers, and digital health companies.

Industry Overview

The mental health industry in the U.S. has witnessed significant advancements in recent years, particularly as public awareness and acceptance of mental health issues have grown. This trend has led not only to an increase in demand for mental health servi

View Source

Similar Deals

GE HealthCare Intelerad

2026

Merger Medical Imaging Systems United States of America
Novartis AG Avidity Biosciences, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America
Illumina, Inc. SomaLogic

2026

Merger Biotechnology & Medical Research (NEC) United States of America
XenoTherapeutics, Inc. Repare Therapeutics Inc.

2026

Merger Bio Therapeutic Drugs United States of America
Eli Lilly Ventyx Bioscences

2026

Merger Bio Therapeutic Drugs United States of America
MSD (Merck & Co., Inc.) Cidara Therapeutics, Inc.

2026

Merger Proprietary & Advanced Pharmaceuticals United States of America

Spring Health

invested in

Alma

in 2026

in a Merger deal

Disclosed details

Equity Value: $221M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert